Submitted:
28 May 2026
Posted:
03 June 2026
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Methods – Narrative Review
3. Case Presentation
4. Results
5. Discussion
6. Limitations
7. Conclusions
References
- Nordal, R.R.; Thoresen, S.O. Uterine sarcomas in Norway 1956-1992: incidence, survival and mortality. Eur. J. Cancer 1997, 33(6), 907–11. [Google Scholar] [CrossRef] [PubMed]
- Clarke, M.A.; et al. Hysterectomy-Corrected Uterine Corpus Cancer Incidence Trends and Differences in Relative Survival Reveal Racial Disparities and Rising Rates of Nonendometrioid Cancers. J. Clin. Oncol. 2019, 37(22), 1895–1908. [Google Scholar] [CrossRef] [PubMed]
- Norris, H.J.; Taylor, H.B. Mesenchymal tumors of the uterus. I. A clinical and pathological study of 53 endometrial stromal tumors. Cancer 1966, 19(6), 755–66. [Google Scholar] [CrossRef] [PubMed]
- Ricci, S.; Stone, R.L.; Fader, A.N. Uterine leiomyosarcoma: Epidemiology, contemporary treatment strategies and the impact of uterine morcellation. Gynecol. Oncol. 2017, 145(1), 208–216. [Google Scholar] [CrossRef] [PubMed]
- Brooks, S.E.; et al. Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999. Gynecol. Oncol. 2004, 93(1), 204–8. [Google Scholar] [CrossRef] [PubMed]
- Sherman, M.E.; Devesa, S.S. Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus. Cancer 2003, 98(1), 176–86. [Google Scholar] [CrossRef] [PubMed]
- Mourits, M.J.; et al. Tamoxifen treatment and gynecologic side effects: a review. Obstet. Gynecol. 2001, 97 5 Pt 2, 855–66. [Google Scholar] [CrossRef] [PubMed]
- Yildirim, Y.; et al. Development of uterine sarcoma after tamoxifen treatment for breast cancer: report of four cases. Int. J. Gynecol. Cancer 2005, 15(6), 1239–42. [Google Scholar] [CrossRef] [PubMed]
- Homer, L.; et al. [Uterine sarcoma associated with tamoxifen use after breast cancer: Review of the pathogenesis]. J. Gynecol. Obstet. Biol. Reprod. 2009, 38(8), 629–33. [Google Scholar] [CrossRef] [PubMed]
- Mark, R.J.; et al. Postirradiation sarcoma of the gynecologic tract. A report of 13 cases and a discussion of the risk of radiation-induced gynecologic malignancies. Am. J. Clin. Oncol. 1996, 19(1), 59–64. [Google Scholar] [CrossRef] [PubMed]
- Meredith, R.F.; et al. An excess of uterine sarcomas after pelvic irradiation. Cancer 1986, 58(9), 2003–7. [Google Scholar] [CrossRef] [PubMed]
- Launonen, V.; et al. Inherited susceptibility to uterine leiomyomas and renal cell cancer. Proc. Natl. Acad. Sci. U S A 2001, 98(6), 3387–92. [Google Scholar] [CrossRef] [PubMed]
- Yu, C.L.; et al. Cause-specific mortality in long-term survivors of retinoblastoma. J. Natl. Cancer Inst. 2009, 101(8), 581–91. [Google Scholar] [CrossRef] [PubMed]
- Liao, Q.; Wang, J.; Han, J. Clinical and pathological analysis on 106 cases with uterine sarcoma]. Zhonghua Fu Chan Ke Za Zhi 2001, 36(2), 104–7. [Google Scholar] [PubMed]
- Menczer, J. Uterine sarcoma in Israel: a study of 104 cases. Gynecol. Oncol. 1985, 22(3), 380. [Google Scholar] [CrossRef] [PubMed]
- Hicks, G.; et al. Spontaneous uterine perforation secondary to uterine leiomyosarcoma presenting as acute abdomen with haemoperitoneum. J. Obstet. Gynaecol. 2010, 30(2), 211–2. [Google Scholar] [CrossRef] [PubMed]
- Kyousuke Takeuchi, M.S.; Yoshida, Ai; Yamashita, Shino; Tsujino, Taro; Nishino, Riichiro. K.M.C. Department of Obstetrics and Gynecology, Kobe, Japan., Spontaneous Uterine Perforation Secondary to Leiomyosarcoma Arising in a Uterine Leiomyoma. Open J. Obstet. Gynecol. 2014. [Google Scholar]
- Khouloud Boussouni 1, M.B.; Rachida Dafiri, 1. Spontaneous uterine rupture due to uterine leiomyosarcoma/ Rupture utérine spontanée sur léiomyosarcome utérin. Pan Afr. Med. J. (PAMJ) 2016. [Google Scholar]
- 19. Stacey Sassaman M.D., M.S., Wojciech Ryncarz M.D.2, Emily Hand M.D.3, Shaun DeBow M.D.4, Daniel and F.M.D.a.R.R. M.D.6, Spontaneous Uterine Perforation Secondary to Uterine Carcinosarcoma Presenting as Acute Abdomen with Pneumoperitoneum. World J. Gynecol. Women’s Health 2024.
- Malihe Hasanzadeh, A.H.L.; Nazari Fathabad, Mohadeseh; Mohammadian, Naama; Moloudian, Matin. Severe Hemoperitoneum: Spontaneous Rupture of Uterine Leiomyosarcoma: A Rare Case. J. Obsterics Gynecol. Cancer Res. 2025. [Google Scholar] [CrossRef]



| Author (year) | Age (years) | Presenting symptoms | Indication for Exploratory Laparotomy | Intraoperative Findings | Surgical Procedure performed | Histopathological Diagnosis | Outcome/ Follow- up |
| Hicks et al., 2010 [16] | 52 | Acute abdomen, anemia | Hemoperitoneum | Large necrotic uterine mass | Total abdominal hysterectomy (TAH) | Undifferentiated uterine sarcoma | Limited follow-up reported |
| Takeuchi et al., 2014 [17] | 59 | Sudden abdominal pain, shock | Acute abdomen of unclear origin | Uterine perforation with active intraperitoneal bleeding | TAH | Uterine leiomyosarcoma | Disease progression during follow-up |
| Boussouni et al., 2016 [18] | 43 | Acute abdominal pain, peritonitis | Suspected hollow-viscus perforation | Spontaneous uterine rupture with generalized peritonitis | TAH + Bilateral Salpingo-Oophorectomy (BSO) | Uterine leiomyosarcoma | Uneventful recovery; adjuvant therapy administered |
| Sassaman et al., 2024[19] | 69 | Acute abdominal pain, sepsis, pneumoperitoneum (no gynecologic symptoms) | Suspected perforated viscus with sepsis | Enlarged necrotic uterus with fundal perforations and purulent peritoneal fluid | TAH + BSO + partial omentectomy | Uterine carcinosarcoma (FIGO stage IIIA) with heterologous rhabdomyosarcoma component | Discharged on postoperative day 13; referred for adjuvant chemo/radiotherapy planned |
| Hasanzadeh et al., 2025 [20] | 44 | Acute abdominal pain, hemoperitoneum | Suspected intra-abdominal hemorrhage | Ruptured intramural/subserosal uterine mass | TAH + BSO | Uterine leiomyosarcoma | Disease-free at 6 month follow-up |
| Present case, 2024 | 45 | Acute abdominal pain | Feculent peritonitis from suspected colonic perforation | Direct sigmoid colon invasion by large uterine mass | TAH + BSO + en bloc sigmoidectomy + colostomy + appendectomy | High-grade uterine leiomyosarcoma | Adjuvant chemotherapy initiated; disease-free at 1-year follow-up |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).